NAPANEE, ON, March 2, 2020 /CNW/ - VIVO Cannabis Inc.
(TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the
"Company") is proud to congratulate the chair of its board
of directors, Paul Lucas, on his
receipt of the 2020 Lifetime Achievement Award from Life Sciences
Ontario. This award is in recognition of Mr. Lucas'
exceptional leadership and contributions to the development of the
life sciences sector in Canada,
his commitment to the community and his passion for improving the
quality of life for Canadians.
![VIVO Cannabis (CNW Group/VIVO Cannabis Inc.) VIVO Cannabis (CNW Group/VIVO Cannabis Inc.)](https://mma.prnewswire.com/media/1097380/VIVO_Cannabis_Inc__VIVO_Chair__Paul_Lucas__Receives_Lifetime_Ach.jpg)
Mr. Lucas is a highly respected leader in the Canadian
pharmaceutical and life science industries. Starting his career
with Eli Lilly and McNeil Pharmaceutical, he then joined
GlaxoSmithKline, where he served as President and CEO from 1994
until his retirement in 2012. Among his many accomplishments, Mr.
Lucas was instrumental in setting up the MBiotech program at the
University of Toronto, where he was a
member of the Principal's Advisory Council. He also played a major
role in attracting numerous investments to the Canadian life
sciences sector developing many life sciences organizations that
continue to exist today.
"We are proud and honoured to have the benefit of Paul's
knowledge and expertise as we continue to grow VIVO's business,"
said Barry Fishman, CEO of VIVO.
"Paul's career is marked by outstanding achievements, unwavering
dedication and commitment to the life sciences community. We are
incredibly fortunate to have Paul as the Chair of VIVO, setting the
standard for integrity, strategic focus and governance in this
nascent industry."
Previous award winners include Dr. Calvin Stiller, a public policy champion
instrumental in founding the Robarts Research Institute in
London, the Ontario Institute for
Cancer Research and MaRS, and Dr. Henry
Friesen, a distinguished Canadian scientist, past president
of the Medical Research Council of Canada, past president of the National Cancer
Institute of Canada and founding
chair of Genome Canada.
"Throughout my career, I have aspired to create a meaningful
impact by stimulating innovation, mentoring the next generation of
leadership and enhancing business success," said Mr. Lucas. "I am
humbled to be joining the ranks of previous award recipients."
In addition to his work with VIVO, Mr. Lucas currently serves as
chair of the board of directors of EcoSynthetix Inc. and Induran
Ventures Inc., and as a director of RnA Diagnostics Inc. He
previously served as a member of the board of trustees of Queen's
University, as chair of the board of directors of Canada's Research-Based Pharmaceutical
Companies (Rx&D), Altimed Pharmaceuticals and Life Sciences
Ontario, and as a director of Biochem Pharma, the Toronto Regional
Research Alliance, Montreal InVivo, AllerGen, the Ontario Genomics
Institute and Select Therapeutics. In 2010, he co-chaired the
Coalition for Action on Innovation in Canada (CAIC) with John P Manley, P.C.,
O.C.
About VIVO Cannabis™
VIVO, based in Napanee,
Ontario, is recognized for trusted, high-quality products
and services. It holds production and sales licences from Health
Canada and operates world-class indoor cultivation facilities with
proprietary plant-growing technology. VIVO has a collection of
premium brands targeting unique customer segments, including Beacon
Medical™, FIRESIDE™, Canna Farms™ and Lumina™. In August 2018, VIVO acquired Canna Farms, a premium
cannabis company based in Hope, British
Columbia. Canna Farms was B.C.'s first Licensed Producer and
has several years of craft cultivation experience and expertise, as
well as a significant patient base and positive cash flow. The
Company is significantly expanding its production capacity and
pursuing partnership and product development opportunities
domestically, as well as in select international markets, including
Germany and Australia. VIVO also operates Harvest
Medicine, a patient-centric and highly scalable network of
specialty medical cannabis clinics as well as a free telemedicine
service. VIVO has a healthy balance sheet and is well-positioned to
accelerate its growth in Canada
and internationally.
SOURCE VIVO Cannabis Inc.